Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease-Reference-Cited by-同舟云学术

Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease

Published:2008-03-15 Issue:6 Volume:177 Page:646-653
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Mekontso Dessap Armand,Leon Rusel,Habibi Anoosha,Nzouakou Ruben,Roudot-Thoraval Françoise,Adnot Serge,Godeau Bertrand,Galacteros Frederic,Brun-Buisson Christian,Brochard Laurent,Maitre Bernard

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference42 articles.

1. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem.Bull World Health Organ2001;79:704–712.

2. Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease

3. Charache S. Sickle cells and sudden death.J Lab Clin Med1994;124:473–474.

4. Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death

5. Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venoarterial Extracorporeal Membrane Oxygenation Therapy in Patients with Sickle Cell Disease: Case Series and Review for Intensive Care Physicians;Journal of Intensive Care Medicine;2024-08-14

2. Deep Learning-Based Red Blood Cell Classification for Sickle Cell Anemia Diagnosis Using Hybrid CNN-LSTM Model;Traitement du Signal;2024-06-26

3. Unexpected Death of a Sickle Cell Disease Patient: A Case Report and Literature Review;Cureus;2024-06-18

4. Refractory cor pulmonale under extracorporeal membrane oxygenation for acute respiratory distress syndrome: the role of conversion to veno-pulmonary arterial assist—a case series;Frontiers in Medicine;2024-04-25

5. Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome;PLOS ONE;2024-04-18